Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

CONTEXT: Current osteoporosis medications increase bone mineral density (BMD) modestly and reduce, but do not eliminate, fracture risk. Attempts to improve efficacy by administering anabolic agents and bisphosphonates concomitantly have been unsuccessful. Conversely, 12 months of concomitant denosum...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Burnett-Bowie, Sherri-Ann M., Zhu, Yuli, Foley, Katelyn, Lee, Hang, Neer, Robert M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2014
Soggetti:
Endocrine Care
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010689/
https://ncbi.nlm.nih.gov/pubmed/24517156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-4440
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi